Yinfeng Kang

机构：South China Agricultural University, Sun Yat-sen University, Guangdong Academy of Medical Sciences, Sun Yat-sen University Cancer Center · ORCID：0000-0001-9570-848X

发表论文 54 篇 · 总被引 1373 次 · h-index 25

代表论文

• PD-1 + CXCR5 − CD4 + Th-CXCL13 cell subset drives B cells into tertiary lymphoid structures of nasopharyngeal carcinoma (2021 · Journal for ImmunoTherapy of Cancer · 被引 97)
• A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV (2023 · Cell Host & Microbe · 被引 76)
• How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection (2022 · Viruses · 被引 73)
• Protective anti-gB neutralizing antibodies targeting two vulnerable sites for EBV-cell membrane fusion (2022 · Proceedings of the National Academy of Sciences · 被引 62)
• Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants (2022 · Nature Communications · 被引 58)
• The Status and Prospects of Epstein–Barr Virus Prophylactic Vaccine Development (2021 · Frontiers in Immunology · 被引 53)